BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3920153)

  • 1. Specificity of antibodies to Newcastle disease virus.
    Powell JA; Kano K; Milgrom F
    Int Arch Allergy Appl Immunol; 1985; 76(4):336-40. PubMed ID: 3920153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to Newcastle disease virus in various human diseases.
    Powell JA; Kano K; Milgrom F
    Int Arch Allergy Appl Immunol; 1985; 76(4):331-5. PubMed ID: 3920152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the Paul-Bunnell antigen-antibody system. III. Detection of a Paul-Bunnell-related antigen in syphilis and leprosy.
    Morito T; Kano K; Milgrom F
    Int Arch Allergy Appl Immunol; 1983; 71(2):117-21. PubMed ID: 6404840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the specificity of agglutinins against human erythrocytes modified by Newcastle disease virus.
    Pyhälä R; Aho K
    Clin Exp Immunol; 1975 Sep; 21(3):485-92. PubMed ID: 1204257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed agglutination with guinea pig tissue sediments for detection of heterophile antibodies.
    Tamura T; Kano K; Milgrom F
    Diagn Immunol; 1984; 2(2):101-4. PubMed ID: 6437728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on Paul-Bunnel (P-B) antigen-antibody system. I. Two distinct P-B antigens.
    Masaki M; Kano K; Merrick JM; Milgrom F
    Int Arch Allergy Appl Immunol; 1981; 65(3):313-22. PubMed ID: 6165687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of transplantation heterophile antibodies.
    Tamura T; Kano K; Milgrom F
    Transplantation; 1984 May; 37(5):475-8. PubMed ID: 6427994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hanganutziu-Deicher antibodies in infectious mononucleosis and other diseases.
    Morito T; Kano K; Milgrom F
    J Immunol; 1982 Dec; 129(6):2524-8. PubMed ID: 6183336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hanganutziu-Deicher antigen and antibody in pathologic sera and tissues.
    Nishimaki T; Kano K; Milgrom F
    J Immunol; 1979 Jun; 122(6):2314-8. PubMed ID: 109527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic variation of LaSota and genotype VII Newcastle disease virus (NDV) and their efficacy against challenge with velogenic NDV.
    Yang HM; Zhao J; Xue J; Yang YL; Zhang GZ
    Vaccine; 2017 Jan; 35(1):27-32. PubMed ID: 27889255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered recombinant protein products of the avian paramyxovirus type-1 nucleocapsid and phosphoprotein genes for serological diagnosis.
    Zhao N; Grund C; Beer M; Harder TC
    Virol J; 2018 Jan; 15(1):8. PubMed ID: 29325564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the HN Antigenic Difference between the Vaccine Strain and the Challenge Strain of Newcastle Disease Virus on Virus Shedding and Transmission.
    Liu J; Zhu J; Xu H; Li J; Hu Z; Hu S; And XW; Liu X
    Viruses; 2017 Aug; 9(8):. PubMed ID: 28809802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental infection of calves with Newcastle disease virus induces systemic and mucosal antibody responses.
    Subbiah M; Yan Y; Rockemann D; Samal SK
    Arch Virol; 2008; 153(6):1197-200. PubMed ID: 18478179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Newcastle disease virus vaccine antibodies on the shedding and transmission of challenge viruses.
    Miller PJ; Afonso CL; El Attrache J; Dorsey KM; Courtney SC; Guo Z; Kapczynski DR
    Dev Comp Immunol; 2013 Dec; 41(4):505-13. PubMed ID: 23796788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective immunity against Newcastle disease: the role of antibodies specific to Newcastle disease virus polypeptides.
    Reynolds DL; Maraqa AD
    Avian Dis; 2000; 44(1):138-44. PubMed ID: 10737654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to polynucleotides in human sera: antigenic specificity and relation to disease.
    Koffler D; Carr R; Agnello V; Thoburn R; Kunkel HG
    J Exp Med; 1971 Jul; 134(1):294-312. PubMed ID: 4997587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agglutination of particulate antigens in agar gel.
    Milgrom F; Loza U
    J Immunol; 1967 Jan; 98(1):102-9. PubMed ID: 4959909
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhancement of Epstein-Barr virus antibody production in systemic lupus erythematosus patients.
    Stancek D; Robenský J
    Acta Virol; 1979 Mar; 23(2):168-9. PubMed ID: 39442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential role of the Epstein-Barr virus in systemic lupus erythematosus autoimmunity.
    Incaprera M; Rindi L; Bazzichi A; Garzelli C
    Clin Exp Rheumatol; 1998; 16(3):289-94. PubMed ID: 9631751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody response to Newcastle disease virus (NDV) of recombinant fowlpox virus (FPV) expressing a hemagglutinin-neuraminidase of NDV into chickens in the presence of antibody to NDV or FPV.
    Iritani Y; Aoyama S; Takigami S; Hayashi Y; Ogawa R; Yanagida N; Saeki S; Kamogawa K
    Avian Dis; 1991; 35(4):659-61. PubMed ID: 1664717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.